We are serving since 1907

info@alembicusa.com908-393-9604

RnD Icon

Research & Development

Our generic R&D activities are carried out at two R&D centers based in India. We are focused on the development of complex, difficult to produce, high-value treatment options to address the unmet needs of patients and improve health outcomes. More...

Manufacturing Icon

Manufacturing Facilities

Our state-of-the-art manufacturing facilities feature the most advanced technology and quality systems to ensure the delivery of quality products at the appropriate time. More...

New Launch

Timolol Maleate Solution, Gel Forming/Drops;Ophthalmic
Timolol Maleate Solution, Gel Forming/Drops;Ophthalmic
Adapalene; Benzoyl Peroxide; Topical; Gel
Carmustine Injection; Injectable
Chlordiazepoxide Hydrochloride; Clidinium Bromide Capsule; Oral
Chlorthalidone Tablet; Oral
Carmustine Injection; Injectable

Range of Products

Alembic’s Timolol Maleate Ophthalmic Gel Forming Solution in strengths of 0.25% and 0.5% in 5mL bottles is now available

Alembic Pharmaceuticals Ltd.

about image

Bedminster, NJ – Alembic Pharmaceuticals, Inc., is a subsidiary of Alembic Pharmaceuticals Ltd., the oldest pharmaceutical company in India. Alembic Pharmaceuticals Limited., employs more than 8000 people and is one of the most respected, established, and integrated pharmaceutical companies in Asia, supplying products to more than 90 countries around the world. Alembic Pharmaceuticals Ltd., is listed on the Bombay Stock Exchange under the stock symbol APLLTD.

Alembic is a vertically integrated organization, with expertise spanning the entire pharmaceuticals value chain: Research & Development (R&D), Manufacturing and Marketing of finished dosage formulations, as well as active pharmaceutical ingredients and intermediates.

Know More

Our Journey

Touching Lives Over 100 Years

More than a century ago, with the guidance and support of his Highness Maharaja Sayajirao Gaekwad, a great mind with business acumen along with two geniuses of Chemistry, conceived Alembic Chemical Works Company Limited.

Watch our video

Our Interesting Facts

7

Manufacturing (3 API & 4 formulation plant) facilities approved by US FDA and other world regulatory agencies.

260

ANDAs filings (259 ANDA & 1 NDA approved)

132

DMF filings

Media

Press Release USFDA Tentative Approval Bimatoprost Ophthalmic Solution, 0.03%

Aug 06, 2018

Press Release USFDA Tentative Approval Bimatoprost Ophthalmic Solution, 0.03%

Received USFDA Tentative Approval for Bimatoprost Ophthalmic Solution, 0.03%
More...

Press Release USFDA Tentative Approval Ticagrelor Tablets 90mg

Jul 12, 2018

Press Release USFDA Tentative Approval Ticagrelor Tablets 90mg

Received USFDA Tentative Approval for Ticagrelor Tablets 90mg
More...

Press Release USFDA Tentative Approval Iloperidone Tablets

Jul 11, 2018

Press Release USFDA Tentative Approval Iloperidone Tablets

USFDA Approval Received Tentative Approval Iloperidone Tablets
More...

Press Release USFDA Approval Doxycycline Hyclate Capsules USP, 50mg and 100mg

Jun 14, 2018

Press Release USFDA Approval Doxycycline Hyclate Capsules USP, 50mg and 100mg

USFDA gives Approval for Doxycycline Hyclate Capsules USP, 50mg and 100mg
More...

Anti Cancer Drug Manufacturing Unit Inauguration by Chief Minister of Gujarat

Jul 14, 2017

Anti Cancer Drug Manufacturing Unit Inauguration by Chief Minister of Gujarat

An Anti Cancer Drug Manufacturing Unit at Panelav, Halol, Near Vadodara was Inaugurated by Chief Minister of Gujarat Mr. Vijay Rupani on 14th Jul 2017
More...

BW article

Mar 08, 2017

BW article

BW article - India's Most Valuable CEO's
More...